Kelsey’s recent PNA5 paper is published in Experimental Neurology

The most recent paper focused on the use of a glyco-peptide, PNA5, which was delievered systemically in mice over-expressing human alpha-synuclien. These mice had an improvement to their cognitive symptoms. This improvement was associated with a reduction in neuroinflammation within the hippocampus, and a reduction in specific circulating inflammatory markers.

Read the full paper here: DOI: 10.1016/j.expneurol.2024.114926 PMID: 39153685